These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 23097076)

  • 1. High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
    Hen Y; Iguchi N; Machida H; Takada K; Utanohara Y; Sumiyoshi T
    Heart Vessels; 2013 Nov; 28(6):742-9. PubMed ID: 23097076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the quantitative extent of late gadolinium enhancement and burden of nonsustained ventricular tachycardia in hypertrophic cardiomyopathy: A delayed contrast-enhanced magnetic resonance study.
    Weissler-Snir A; Hindieh W; Spears DA; Adler A; Rakowski H; Chan RH
    J Cardiovasc Electrophysiol; 2019 May; 30(5):651-657. PubMed ID: 30680853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy.
    McLELLAN AJ; Ellims AH; Prabhu S; Voskoboinik A; Iles LM; Hare JL; Kaye DM; Macciocca I; Mariani JA; Kalman JM; Taylor AJ; Kistler PM
    J Cardiovasc Electrophysiol; 2016 May; 27(5):571-80. PubMed ID: 26840595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late gadolinium enhancement of cardiac magnetic resonance imaging indicates abnormalities of time-domain T-wave alternans in hypertrophic cardiomyopathy with ventricular tachycardia.
    Sakamoto N; Sato N; Oikawa K; Karim Talib A; Sugiyama E; Minoshima A; Tanabe Y; Takeuchi T; Akasaka K; Saijo Y; Kawamura Y; Hasebe N
    Heart Rhythm; 2015 Aug; 12(8):1747-55. PubMed ID: 25916568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsustained Ventricular Tachycardia Is Independently Associated With Sustained Ventricular Arrhythmias in Nonischemic Dilated Cardiomyopathy.
    Piers SR; Androulakis AF; Yim KS; van Rein N; Venlet J; Kapel GF; Siebelink HM; Lamb HJ; Cannegieter SC; Man SC; Zeppenfeld K
    Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e009979. PubMed ID: 35089806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy.
    Spinner JA; Noel CV; Denfield SW; Krishnamurthy R; Jeewa A; Dreyer WJ; Maskatia SA
    Am J Cardiol; 2016 Apr; 117(8):1342-8. PubMed ID: 26892450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia.
    Dimitrow PP; Klimeczek P; Vliegenthart R; Pasowicz M; Oudkerk M; Podolec P; Tracz W; Dubiel JS
    Int J Cardiovasc Imaging; 2008 Jan; 24(1):77-83; discussion 85-7. PubMed ID: 17624806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
    Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
    J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of premature ventricular contractions beyond nonsustained ventricular tachycardia is related to the myocardial extracellular space expansion in patients with hypertrophic-cardiomyopathy.
    Chung H; Park CH; Kim Y; Kim JY; Min PK; Yoon YW; Lee KA; Lee BK; Hong BK; Kim TH; Rim SJ; Kwon HM; Choi EY
    Clin Cardiol; 2020 Nov; 43(11):1317-1325. PubMed ID: 32815161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Myocardial Disarray in Patients With Hypertrophic Cardiomyopathy and Ventricular Arrhythmias.
    Ariga R; Tunnicliffe EM; Manohar SG; Mahmod M; Raman B; Piechnik SK; Francis JM; Robson MD; Neubauer S; Watkins H
    J Am Coll Cardiol; 2019 May; 73(20):2493-2502. PubMed ID: 31118142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
    Appelbaum E; Maron BJ; Adabag S; Hauser TH; Lesser JR; Haas TS; Riley AB; Harrigan CJ; Delling FN; Udelson JE; Gibson CM; Manning WJ; Maron MS
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):78-85. PubMed ID: 22135401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation.
    Rathod RH; Prakash A; Powell AJ; Geva T
    J Am Coll Cardiol; 2010 Apr; 55(16):1721-8. PubMed ID: 20394877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal left ventricular strain in hypertrophic cardiomyopathy: correlation with nonsustained ventricular tachycardia.
    Correia E; Rodrigues B; Santos LF; Moreira D; Gama P; Cabral C; Santos O
    Echocardiography; 2011 Aug; 28(7):709-14. PubMed ID: 21564281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
    Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.
    Tezuka D; Kosuge H; Terashima M; Koyama N; Kishida T; Tada Y; Suzuki JI; Sasano T; Ashikaga T; Hirao K; Isobe M
    Heart Vessels; 2018 May; 33(5):513-520. PubMed ID: 29168014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical significance of cardiovascular magnetic resonance adenosine stress-induced myocardial perfusion defect in hypertrophic cardiomyopathy.
    Kim EK; Lee SC; Chang SA; Jang SY; Kim SM; Park SJ; Choi JO; Park SW; Jeon ES; Choe YH
    J Cardiovasc Magn Reson; 2020 May; 22(1):30. PubMed ID: 32366254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation the relationship between myocardial fibrosis and left ventricular torsion measured by cardiac magnetic resonance feature-tracking in hypertrophic cardiomyopathy patients with preserved ejection fraction.
    Zhong Y; Li C; Yu Y; Du Y; Bai Y; Wang X; Dai X; Fan G; Wang G
    Int J Cardiovasc Imaging; 2024 Apr; 40(4):921-930. PubMed ID: 38448705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMR assessment and clinical outcomes of hypertrophic cardiomyopathy with or without ventricular remodeling in the end-stage phase.
    Cheng S; Choe YH; Ota H; Cui C; Yin G; Lu M; Li L; Chen X; Prasad SK; Zhao S
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):597-605. PubMed ID: 29071521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.